Pacific Biosciences of California, Inc. (PACB)

PACB Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for PACB stock have an average target of 2.92, with a low estimate of 2.00 and a high estimate of 6.00. The average target predicts an increase of 54.91% from the current stock price of 1.89.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.00	$2.92	$2.50	$6.00
Change	+6.10%	+54.91%	+32.63%	+218.30%

* Price targets were last updated on Nov 11, 2024.

Analyst Ratings

The average analyst rating for PACB stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	4	4	4	4	3	3
Buy	4	4	4	4	4	4
Hold	7	7	7	7	8	6
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	15	15	15	15	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
John Sourbeer UBS	UBS	Strong Buy → Hold Downgrades $2	Strong Buy → Hold	Downgrades	$2	+6.10%	Nov 11, 2024
Sung Ji Nam Scotiabank	Scotiabank	Buy Maintains $7 → $6	Buy	Maintains	$7 → $6	+218.30%	Nov 11, 2024
David Westenberg Piper Sandler	Piper Sandler	Hold Maintains $2 → $2.5	Hold	Maintains	$2 → $2.5	+32.63%	Nov 11, 2024
Sung Ji Nam Scotiabank	Scotiabank	Buy Maintains $8 → $7	Buy	Maintains	$8 → $7	+271.35%	Aug 28, 2024
Mason Carrico Stephens & Co.	Stephens & Co.	Buy Maintains $3.5 → $2.5	Buy	Maintains	$3.5 → $2.5	+32.63%	Aug 13, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

158.66M

Decreased by -20.88%

from 200.52M

Revenue Next Year

192.86M

Increased by 21.56%

from 158.66M

EPS This Year

-1.32

from -1.21

EPS Next Year

-0.68

from -1.32

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	90.89M	78.89M	130.51M	128.30M	200.52M	158.66M	192.86M	252.13M
Revenue Growth	15.60%	-13.20%	65.43%	-1.69%	56.29%	-20.88%	21.56%	30.73%
EPS	-0.55	0.17	-0.89	-1.40	-1.21	-1.32	-0.68	-0.57
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	18	18	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028	2029
High	167.0M	221.6M	298.2M
Avg	158.7M	192.9M	252.1M
Low	151.6M	169.6M	194.0M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028	2029
High	-16.7%	39.6%	54.6%
Avg	-20.9%	21.6%	30.7%
Low	-24.4%	6.9%	0.6%

EPS Forecast

EPS	2024	2025	2026	2027	2028	2029
High	-0.88	-0.56	-0.34
Avg	-1.32	-0.68	-0.57
Low	-1.40	-0.83	-0.74

EPS Growth

EPS Growth	2024	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.